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At present, the diagnosis of many cancers relies on the 
subjective interpretation of morphological changes 
in biopsy samples. This usually provides only late 
diagnosis. Early detection, which can provide more 
successful therapy, is expected to be possible by iden-
tification of tumour markers in physiological samples. 
Immunoassay used at present for this purpose has 
several drawbacks. It is applicable only for known 
markers, can usually detect only one marker at a 
time, and may also fail to detect a marker when there 
exist conditions, which may mask or prevent the in-
teraction between antigen and the antibody. We have 
developed a high performance liquid chromatogra-
phy-laser induced fluorescence (HPLC-LIF) tech-
nique to detect and record simultaneously spectra and 
chromatograms of physiological samples, which will 
enable the detection of multiple ‘markers’ in a single 
physiological sample in a short time. Samples of saliva 
and serum from normal and oral cancer subjects have 
been studied with the set up. The present studies show 
that body fluids like saliva and serum of normal, pre-
malignant and malignant subjects have substantially 
different protein profiles. By simultaneous recording 
of the chromatographic peaks and corresp nding 
fluorescence spectra, it is possible to carry out 
unambiguous discrimination between normal, pre-
malignant and malignant cases even when markers 
are present in femto/subfemtomole quantities, which 
should assist in early diagnosis of neoplasia. 
 
IT  is recognized that even small primary cancers shed 
viable tumour cells into the circulatory system. In the 
progression of a tumour from a homogeneous proliferat-
ing clone to a group of heterogeneous sub-populations of 
cells, the cells generate an entire array of enzymes and 
surface molecules1. These molecules, as well as those 
produced by the tumour’s host in response to the pres-
ence of the tumour are generally known as tumour markers. 
They can be used to detect the presence of malignancy 
when located in clinical samples like cytologi al smears 
and biopsied tissue samples or body fluids2. At preent, 
the diagnosis of many cancers, especially oral cancer, 
depends almost completely on histomorphological analy-
sis of stained tissue sections, which provide only late 
diagnosis. On the other hand, biomarkers could be used, 
not only for early detection, but also for identificatio  of 
putative pre-malignant lesions, prognosis of disease, 
monitoring of therapy, and early detection of recurrence 
or development of second primary cancer3. At present, 
immunoassay is the only readily available technique for 
detection of tumour markers4. Unfortunately, so far no 
single marker has been identified in oral cance that is 
not present in normal or benign lesions. Immuno methods 
are generally applicable for detection of only one marker 
at a time. Moreover, failure of immuno methods does not 
necessarily prove that the marker is absent. Anything that 
masks or prevents the interaction of the antibody and 
antigen will lead to a false-negative result. It is highly 
probable that a combination of several markers, detected 
simultaneously, will definitely improve the chances of 
success in early detection of cancer. By combining ultra-
sensitive optical methods like laser-induced fluorescence, 
with highly efficient separation techiques like HPLC or 
CE (capillary electrophoresis) we can detect ultra trace 
amounts of individual biomolecules in complex, multi-
component physiological systems5–8. The use of laser-
induced fluorescence has several advantages over con-
ventional fluorescence spectroscopy. They are (i) the 
limited influence of the stray light effects due to high 
monochromaticity, (ii) accurate focusing capability of the 
excitation source on to the microbore capillary flow cell, 
resulting in excitation of picolitre amounts of sample 
without loss of the excitation energy and (iii) complete 
elimination of excitation energy by use of dielectric laser 
mirrors, leading to very low background. In our labora-
tory, we have set up an HPLC-LIF system for detection 
of tumour markers in various forms of malignancy. The 
system is capable of detecting and recording the spectra 
of femtomoles (or still lower quantities) of proteins as 
they flow past a probing laser beam. The sensitivity can 
be enhanced by several orders of magnitude if needed. 
Typical studies on saliva and serum samples from normal 
and oral cancer subjects have shown that the set-up pro-
vides a very powerful technique for detection of several 
‘markers’ in a single sample. The results in the present 
work demonstrate that the technique represents a possible 
powerful method for early detection of premalignancy, 
malignancy and recurrence, as well as monitoring of 
therapy. 
 Myoglobin, insulin, creatine kinase, bovine serum al-
bumin (BSA), known tumour markers, as well as tri-
fluoroacetic acid for HPLC were procured from Sigma 
and used as such. HPLC grade solvents acetonitrile, 
methanol, water and isopropanol were obtained from E. 
Merck. 
 The experimental system consisted of the following 
subunits that have been assembled together to form the 
final setup: HPLC, laser excitation source, CCD-spec-
trograph for recording fluorescence spectrum and mono-
chromator-PMT-lock-in-amplifier for chromatographic 
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peak-detection. Figure 1 shows the layout of the experi-
mental set-up. The HPLC system (Hewlett Packard series 
1100, USA) has a quaternary pump, a degasser, solvent 
reservoir cabinet, and a manual injector (Rheodyne). A 
reverse phase biphenyl narrow bore column (Vydac) was 
connected to this system using PEEK tubing (Upchurch 
Scientific). The effluent from the column was passed 
through a 75 mm i.d. quartz capillary (Hewlett Packard) 
using finger-tight fittings (Upchurch Scientific) and 
1/16in.unions (Agilent). 
 An intra cavity frequency doubled Ar+ lase  (Innova 
90C FreD) at 257 nm, obtained by doubling 514.5 nm 
with a BBO crystal was used for fluorescence excitation. 
The use of 257 nm for excitation has several advantages. 
All three fluorophores, phenylalanine, tryptophan and 
tyrosine present in proteins have reasonably good ab-
sorption at this wavelength. Also the Raman line from 
the solvents is close to the excitation line (~ 288 m), and 
does not interfere with the fluorescence emission ob-
served usually above 300 nm. The laser beam is tightly 
focused onto the capillary using a focusing lens 
(f = 2 cm). The plasma lines and fundamental were re-
moved from the excitation line by using two dichroic 
mirrors, which reflect the 257 nm radiation to the lens 
transmitting all other wavelengths. A power of around 5–
10 mW on the capillary surface was found to be suffi-
cient for excitation. The fluorescence and Raman signals 
emitted were collected on both sides of the capillary at 
90° to the excitation beam. On one side the collected sig-
nal was focused on to the spectrograph (Acton) through a 
third 257 nm reflecting dichroic mirror. The dispersed 
fluorescence and Raman signals were recorded with a 
CCD (Roper Scientific, Model-RTE/CCD-128-HB) inter- 
 
 
 
 
Figure 1. Experimental set-up for HPLC-LIF. I, Injector; HP, Pump; 
CL, Column; CP, Quartz capillary; L, Lens; F, Filter, M, Monochro-
mator; C, CCD; CH, Chopper; P, PMT; PA, Preamplifier; LIA, Lock-in 
amplifier; PC, Computer; A, Ar+ laser; DF, Dichroic filter. 
faced to a PC. A 600 g/mm grating, blazed at 300 nm was 
us d for recording the spectra. Fluorescence and Raman 
signals emitted on the other side of the capillary were 
collected using another lens system and focused on to the 
entrance slit of a DH10 (SPEX) monochromator. The 
signal was chopped using an EG&G Model 651 chopper 
and detected with a Hamamatsu R 453 Photomultiplier. 
Output of the PMT was fed into an EG&G preamplifier 
followed by a digital lock-in-amplifier (EG&G) inter-
faced to a PC. 
 The biological samples, i.e. blood and saliva of cancer 
patients were acquired from College of Dental Surgery, 
M nipal Academy of Higher Education. Normal samples 
were collected from healthy volunteers. These samples 
were analysed within a few hours of collection, though 
n  changes in chromatogram or spectra are observed due 
to storage for several hours. Blood samples were stored 
at room temperature for about 30 min, centrifuged at 
3000 rpm for 5 min and the separated serum was col-
lected. The normal and malignant serum samples were 
usually diluted 100 to 500 times with ultra pure water. A 
20 ml sample was injected into the HPLC. Both malig-
nant and normal saliva samples were diluted 10 times 
with ultra pure water and 20 ml injected into the HPLC 
system. Because of the small dimension of the capillary 
and tight focusing of the laser (< 10 mm), the alignment 
of the ystem is rather critical. This is done conveniently, 
by maximizing the Raman signal from the effluent 
(water, acetonitrile, and methanol). As each chromato-
graphic peak appeared in the lock-in system, corres-
pon ing fluorescence spectra were recorded using the 
spectrograph CCD system. A chromatogram of the sample 
and spectra of all the components in it are thus available at 
the end of a run. 
 The spectral recording and chromatographic detection 
sensitivity of the set-up was tested using proteins like 
insulin, myoglobin, creatine kinase and BSA. Figure 2 A 
shows the chromatographic peaks for standard solutions 
of BSA. Spectra from the blank and from 90 fm of BSA 
are shown in Figure 2 B. Plot of normalized chromato-
graphic signal (background subtracted) of BSA versus 
the quantity of BSA injected into the HPLC is shown in 
Figure 2 C. The limit of detection taken as 3 times back-
ground noise is ~ 8 fmoles for the present system with 
lock-in detection. In the CCD-spectrograph the dark 
noise is 80 counts/s. The spectrum was recorded for 5 s 
and an estimate of sensitivity taken as thrice the dark 
count (1200 counts) is also of the same order, viz. 
~ 7 fmol. As will be seen later, this sensitivity is more 
than needed for real-life samples. Further increase in sen-
sitivity can be achieved on the spectrograph, if needed, 
by using a high NA microscope objective for collection 
of fluorescence6, or replacing the f/4 spectrograph with 
one with lower f value9. The limit of detection under such 
conditions can be in the subfemtomole region. The sensi-
tivity of the lock-in system can easily reach sub-femto-
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Figure 2. A, Chromatograms of different amounts of BSA, a, blank; b, 90 fm; c, 181 fm; d, 362 fm and 
e, 724 fm. B, Fluorescence spectra of 90fm BSA (100 mm slit width, 5 s accumulation). a, Background 
spectrum; b, Spectrum before background subtraction; b–a, Spectrum after background subtraction. C, 
calibration curve for BSA. 
 
molar level if needed, by replacing the monochromator 
with band pass filters, using high PMT voltages and laser 
power and better signal processing10. 
 Figure 3 shows chromatograms of saliva samples from 
different subjects. Saliva from healthy volunteers with no 
oral malignancy or tobacco habit is taken as normal. Fig-
ure 3 A shows chromatogram from normal volunteers 
belonging to different age groups, sex and reproductive 
stages. It can be seen that all the chromatograms are ba-
sically similar though there are some minor differences. 
The number of major peaks and relative intensities are 
very similar in spite of the fact that the subjects corre-
spond to widely varying physiological conditions. There 
are only two major peaks in the early elution, (up to 
15min) and 5 major peaks in the later stages. Chroma-
tograms of volunteers with tobacco habits but no malig-
nancy did show some changes. However, they still do not 
show any major peaks other than those present in normal 
s mples (Figure 3 B) in the early elution up to 15 min. 
 Pre-malignant phases of oral cancer include conditions 
like lichen planus, leukoplakia, erythroplakia, submucous 
fi rosis, etc. We have studied saliva samples from many 
such subjects. Figure 4 shows typical examples of these 
ca es. The most noticeable diff rence from normal 
ubjects is the appearance of several strong additi al 
peaks in the early elution. In order to identify which of 
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these indicate progression to malignancy, several cases 
have to be studied and followed up. This is being done  
at present and will be completed over a period of 1–2 
years. 
 Figure 5 shows similar results for established malig-
nancy cases in various stages. Once again, several addi-
tional peaks are observed in these samples. Comparison 
of the normal, pre-malignant and malignant sample 
chromatograms clearly shows that while all norm l saliva 
samples more or less matched with one another, pre-ma-
lignant and malignant samples are very different from 
normal. New peaks are observed and some of the peaks 
in normal saliva show drastic decrease in some of the 
malignant cases. The spectra of various fractions of nor-
mal, pre-malignant and malignant saliva are shown in 
Figure 6. As can be seen, there is considerable variation  
 
 
 
 
Figure 3. A, Chromatograms of normal saliva samples. , Female, 38 
years, Mother of two; b, Male, 23 years; c, Male, 28 years; d, Female, 
33 years, Pregnant. B, Chromatograms of smoker’s saliva samples. e, 
Male, 38 years, 3–4 cigarettes a day; f, Male, 43 years, 6–7 cigarettes a 
day; g, Male, 28 years, 10– 2 cigarettes a day. The * in this and subse-
quent figures indicates a peak coming from the solvents in some of the 
runs, and is variable from run to run. $, The dips observed at the strong 
peaks in this and subsequent figures result from shutting off of the 
recording system due to excess signal overloading. 
in peak positions, intensities, half widths and shapes of 
the emission bands among the different chroma ographic 
peaks. 
 As seen from Figure 6, spectra of different protein 
components in saliva show subtle differences between 
normal, pre-malignant and malignant cases. Some of the 
s ectra have very low intensity, while others are very 
strong. Many of them are similar in shape. It is thus ob-
vious that without their separation on the HPLC column, 
no information on relative spectral characteristics or con-
centrations could have been obtained, even if a total fluo-
rescence spectrum of the sample is available (Figure 6, 
TF).
 It is well known that cancer is not a single disease. It is 
therefore to be expected that the expression of proteins in 
the system need not be the same under different condi-
tions of malignancy or in different stages of malignancy. 
The number of peaks, and intensities which are propor-
tional to their relative concentrations, as well as the re-
tention times in the various samples cannot thus be 
expected to resemble each other closely. This is clearly 
shown by the results in Figures 3, 4 and 5. Thus any 
 
 
 
 
Figure 4. Chromatograms of oral premalignancy saliva samples. a, 
Leukoplakia; b, Lichen planus; c, Submucous fibrosis. 
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Figure 5. Chromatograms of oral malignant saliva samples. a, Carci-
noma buccal mucoa; b, Oropharyngeal carcinoma; c, Squamous cell 
carcinoma of lip. 
 
pattern recognition analysis can be of limited use in 
statistical evaluation or classification of stages of malig-
nancy, etc. The important results to be noted are that, (i)  
all normal samples have the same pattern, (ii) pre-malig-
nant stages have a large number of extra peaks with low 
retention times while normal peaks are still observed, 
and, (iii) malignancy leads to drastic changes even in the 
normal components. 
 Oral cancer is one form of cancer for which not many 
markers have been indicated2 till now. Squamous cell 
antigens (glycoprotein, 44–48 kDa), epithelial keratins, 
immunosuppressive cytokines and cell surface anti-
gens4,11 have been suggested as possible markers. The 
major proteins in normal saliva are mucin, a-amylase and 
lipase with trace levels of immunoglobulins12. Since the 
aim of the present work was to test the capability of our 
system to discriminate between normal, pre- alignant 
and malignant physiological samples, no attempt was 
made to correlate the 5 strong peaks in normal saliva to 
any possible salivary proteins. The enormous increase in 
many of the very weak peaks as well as the decrease in 
some of the peaks in malignant saliva compared to nor-
mal samples clearly show the capability of the system in 
detecting simultaneously even very small changes in the 
molecular species from normal to pre-malignant and ma-
lignant. 
 It should be noted that all the chromatograms were 
recorded with the monochromator set at 340 nm, with 
band pass less than 10 m (2 mm slits). As can be seen 
from the spectra in Figure 6, some of the ‘markers’ have 
their peak intensities in the 300–320 nm, while some oth-
ers have their peaks at 350 nm. Also all the spectra have 
widths greater than 30–40 nm. This shows that the detec-
tion sensitivity of the lock-in system can be increased by 
1–2 orders of magnitude by using band pass filters for 
detection, with simultaneous measurement of background 
fluorescence at a suitable wavelength, say 450– 0 nm, 
for background correction. We are incorporating these 
modifications at present. Normally all the spectra are 
recorded with 100 mm slit, 1 s accumulation and no 
binning of the pixels. For further sensitivity increase, 
slits can be opened up to even 500mm, spectra can be 
accumulated for about 20 s and several pixels (even up to 
100) can be binned. This will increase the sensitivity 2–3 
orders of magnitude. We have combined all these ideas in 
typical test runs (data not shown) and have found that 
sensitivity increases about 1000 times. 
 Intrinsic protein fluorescence comes from the aromatic 
amino acids, tryptophan, tyrosine and phenylalanine. The 
excitation wavelength, 257 nm, in our case, is absorbed 
fairly well by all these three amino ac ds. However, the 
emission maximum of phenylalanine is around 280 nm, 
and its quantum yield is very low. Moreover, energy 
transfer to tyrosine and tryptophan by resonance energy 
transfer is highly likely, and so the bands observed in the 
present studies cannot be from phenylalanine groups. 
Tryptophan emission is known to be highly sensitive to 
the average environment of the molecule13, starting with 
a structured emission at 300 nm in completely nonpolar 
environment, and changing to a broad emission around 
350 nm when exposed to a polar environment. Tyrosine 
in water gives a fluorescence emission around 300 nm; 
the emission being relatively insensitive to polarity and 
more narrowly distributed, compared to tryptophan. Most 
of the ‘markers’ in the present runs are eluted early in the 
run, under highly polar environment (70–50% water/ 
TFA). It is interesting to note that some of these markers 
do exhibit peaks around 300 nm. These peaks could arise 
from either a tyrosine residue or a tryptophan residue in a 
highly hydrophobic environment. However, hydrophobic 
proteins are usually eluted late. Moreover, since similar 
spectral features were recorded for insulin, which has 
similar retention time, 4 tyrosine moieties and no trypto-
phan14, the former possibility is more probable. Detailed 
investigations including ‘on-line’ and ‘off-line’ Surface 
Enha ced Raman Spectroscopy (SERS) on these individ-
ual fractions are now being carried out, to get a better 
understanding of the nature of the proteins and the sig-
nificance of their presence in malignancy. 
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Figure 6. Fluorescence spectra of saliva components of different types N1, PM1 and M1, Fluorescence spectra of component 
with same retention time from Figures 3, 4, and 5; N2, N3 and N4, Fluorescence spectra of different components from same sam-
ple in Figure 3; PM2 and PM3, Fluorescence spectra from two components in different pre-malignant samples from Figure 4; TF, 
Total fluorescence spectrum of normal saliva excited by 257 nm. 
 
 
 We have carried out analysis of serum samples under 
similar conditions. As in the case of saliva, serum sam-
ples from normal subjects were all very similar to one 
another, while samples from malignant cases showed 
many additional peaks, as well as noticeable changes in 
relative concentrations of components. These changes 
can be understood only after correlating results from a 
statistically significant number of subjects under various 
stages of premalignancy, malignancy and metastasis, 
since expression of serum proteins may change signifi-
cantly under such variations. These studies are being car-
ried out at present. 
 HPLC-LIF, combined with on-the-run spectroscopy of 
saliva and serum are capable of providing spectra and 
chromatograms of multicomponent physiological sam-
ples for detection of tumour markers. The method is 
highly sensitive, capable of detecting femto/subfemto 
moles of ‘markers’, and is thus comparable to methods of 
immunoassay, employed at present for this purpose. 
However, unlike immunoassay, which can detect or esti-
ate only one known marker at a time, the present tech-
nique can look at multiple markers in one run, thus 
improving the diagnostic capability. The time required 
for the test is also very short, being less than one hour 
after receiving the sample, since no preprocessing r im-
muno reactions are involved. The present results also 
show that though there are no established markers identi-
fied at pres nt for oral cancer, it may be possible to select 
some of the many new proteins observed in premalig-
nancy and malignancy, as suitable markers. This has to 
be done by analysing data from a sufficiently large num-
ber of samples in each category, like putative premalig-
nancy, various stages of malignancy, recurrence, etc. 
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The most recent and dramatic effect of vitamin A in 
tadpoles is the homeotic transformation of tail to 
limbs, which is characterized by the development of 
ectopic limbs at the site of tail amputation. The mor-
phological changes brought about by vitamin A after 
tail amputation are quite striking and amazing. His-
tological changes include thickening of the epidermis, 
enlargement of the notochord and the nerve cord, 
thickening of the sheath covering the notochord and 
the nerve cord, clumping of the muscles and, above 
all, development of ectopic limbs from the amputated 
tail end. In this communication, the histological 
changes in the tail tissue after vitamin A treatment 
are discussed with reference to homeotic transforma-
tion. 
EVER since the discovery of vitamin A in 1909 (ref. 1) 
and compounds of related structure and function (the 
‘retinoids’), numerous workers started probing the amaz-
ing nature of vitamin A. To head the list were Niazi and 
Saxena2, who first discovered that vitamin A has an in-
hibitory and modifying influence on tail regeneration in 
the tadpoles of Bufo andersonii. Since then, there have 
been several subsequent reports on the effects of vitamin 
A on limb development and regeneration3–7. I  was in 
1992 that the phenomenon of homeotic transformation 
was first reported by Mohanty-Hejmadi t al.8 n Upero-
don systoma, later being confirmed in other species9–11. 
This led us to explore the changes in the tail tissue fol-
lowing vitamin A treatment, in greater detail. Besides, 
the tail in anurans has received little attention probably 
because of its transitory nature. Although extensive work 
has been done on the histological effects of vitamin A on 
limb development and regeneration12,13, the histological 
effects of vitamin A on tail regeneration have not been 
dealt with. Examining the histological changes will im-
prove our understanding of vitamin A-induced homeotic 
transformation, where the tail tissues are converted to 
limb tissues. In Rana tigerina, the ectopic limbs were 
stunted and not well-developed unlike the ectopic limbs 
of Polypedates maculatus, where they resembled the 
normal limbs with well-differentiated digits. It was there-
fore mandatory to study the histological changes in the 
tail tissues and ectopic limbs of R. tigerina fter vitamin 
A treatment. 
Egg masses of the Indian bull frog, R. tigerina were 
collected from nature during the rainy season and raised 
in the laboratory up to the hindlimb bud stage. The tad-
poles were fed with boiled egg and Amaranthus ad libi-
tum. Prior to amputation, the tadpoles were anaesthetized 
in 1 : 400 solution of MS 222 (tricaine methanesulpho-
nate, Sigma), amputated in the middle of their tails and 
reared in conditioned water containing vitamin A 
10 IU/ml (Arovit, Roche). For morphology, the tadpoles 
were treated for 24, 48, 72, 96 and 120 h. After the 
treatment period, they were reared in aerated, conditioned 
water and fixed in formalin only after forelimb emer-
gence or after their death (whichever was earlier). The 
controls were also reared in a similar way, but without 
vitamin A treatment. For histology, the tadpoles were 
treated for 72 h (3 days), since morphological studies 
showed that 72 h was the optimum time to induce maxi-
mum effect in the anurans. Following treatment, the tad-
poles were removed, anaesthetized, their regenerated tails 
amputated and fixed in aqueous Bouin’s fluid on days 1, 
2, 3, 4, 5, 6, 10, 15 and 25 (i.e. both during and beyond 
the period of treatment). The controls were also fixed on 
